{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:33:57Z","timestamp":1787762037907,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The association of cytomegalovirus (CMV) infection with ulcerative colitis (UC) still remains a controversial topic for the clinicians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>In this study, we aimed to elucidate the CMV infection related parameters in the exacerbation of UC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>In this study, 812 UC patients who have admitted to our institution between June 2008 and November 2020 were analyzed retrospectively. CMV infection was diagnosed by the detection of CMV DNA with polymerase chain reaction (PCR) in tissue biopsies with presence of clinical colitis symptoms. CMV negative UC patient group was defined as UC activation group with negative PCR results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>A total of 153 patients met the inclusion criteria during the study period, with a median age of 41.8 years. CMV PCR positivity had been detected in tissue biopsy in 43 (28.1%) UC patients. CMV-positive patients had a statistically significant higher frequency of steroid resistance, treatment with azathioprine, longer disease duration, longer remission, and hospitalization day. The mean C-reactive protein (CRP) level, platelet to lymphocyte ratio (PLR) were higher, and mean albumin level was lower in CMV positive patients, with statistically significance. Also, colectomy and anti-tumor necrosis factor-\u03b1 (TNF-\u03b1) therapy were more frequent in CMV-reactivated group in long-term follow-up. In a multivariable model, steroid resistance, treatment with azathioprine, long disease duration, low albumin value was independently associated with colonic CMV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Steroid resistance, treatment with azathioprine, long disease duration, low albumin levels were significant risk factors for CMV colitis, among patients with UC activation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_616_22","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T06:00:51Z","timestamp":1689314451000},"page":"765-770","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Cytomegalovirus Reactivation in Ulcerative Colitis Patients: Early Indicators"],"prefix":"10.4103","volume":"26","author":[{"given":"LN","family":"Altunal","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Health Sciences University Umraniye Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AS","family":"Ozel","sequence":"additional","affiliation":[{"name":"Health Sciences University Umraniye Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"AK","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Health Sciences University Umraniye Training and Research Hospital, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"R1-20240907","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1007\/s10620-015-3733-6","article-title":"Relationship between cytomegalovirus infection and steroid resistance in inflammatory bowel disease:A meta-analysis","volume":"60","author":"Wu","year":"2015","journal-title":"Dig Dis Sci"},{"key":"R2-20240907","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD:From 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"361","key":"R3-20240907","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"19","author":"Abraham","year":"2009","journal-title":"N Engl J Med"},{"issue":"20","key":"R4-20240907","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3748\/wjg.v20.i2.509","article-title":"Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status","volume":"14","author":"Inokuchi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R5-20240907","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"R6-20240907","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.mib.0000231576.11678.57","article-title":"Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease","volume":"12","author":"Dimitrulia","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R7-20240907","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1038\/ajg.2011.202","article-title":"Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis","volume":"106","author":"Roblin","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R8-20240907","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000479865","article-title":"Diagnosis of cytomegalovirus infection during exacerbation of ulcerative colitis","volume":"96","author":"Levin","year":"2017","journal-title":"Digestion"},{"issue":"10","key":"R9-20240907","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1743-422X-10-43","article-title":"The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China","volume":"1","author":"Yi","year":"2013","journal-title":"Virol J"},{"key":"R10-20240907","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/apt.13124","article-title":"Review article:Cytomegalovirus and inflammatory bowel disease","volume":"41","author":"Sager","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"(Suppl 3)","key":"R11-20240907","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"R12-20240907","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"J Crohns Colitis"},{"key":"R13-20240907","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MIB.0000000000001073","article-title":"Diagnostic accuracy of blood-based tests and histopathology for cytomegalovirus reactivation in inflammatory bowel disease:A systematic review and meta-analysis","volume":"23","author":"Tandon","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"R14-20240907","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis;final report on a therapeutic trial","volume":"2","author":"Trulove","year":"1955","journal-title":"Br Med J"},{"issue":"(Suppl A)","key":"R15-20240907","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease:Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"R16-20240907","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/MEG.0000000000000361","article-title":"Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease:A 10-year tertiary referral center experience","volume":"27","author":"Gauss","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R17-20240907","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cgh.2014.05.026","article-title":"A model for identifying cytomegalovirus in patients with inflammatory bowel disease","volume":"13","author":"Mccurdy","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R18-20240907","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3390\/diagnostics11111952","article-title":"Risk factors of cytomegalovirus reactivation in ulcerative colitis patients:A meta-analysis","volume":"11","author":"Qin","year":"2021","journal-title":"Diagnostics(Basel)"},{"issue":"10","key":"R19-20240907","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2147\/IDR.S149784","article-title":"Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease?A meta-analysis","volume":"14","author":"Lv","year":"2017","journal-title":"Infect Drug Resist"},{"key":"R20-20240907","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jcv.2018.06.002","article-title":"Novel score predicts risk for cytomegalovirus infection in ulcerative colitis","volume":"105","author":"Nowacki","year":"2018","journal-title":"J Clin Virol"},{"key":"R21-20240907","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12876-020-01434-5","article-title":"IgA, albumin, and eosinopenia as early indicators of cytomegalovirus infection in patients with acute ulcerative colitis","volume":"20","author":"Yang","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"R22-20240907","doi-asserted-by":"crossref","first-page":"e0178762","DOI":"10.1371\/journal.pone.0178762","article-title":"Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer:A systematic review and meta-analysis","volume":"12","author":"Song","year":"2017","journal-title":"PLoS One"},{"key":"R23-20240907","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/jomb-2017-0050","article-title":"Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict mucosal disease severity in ulcerative colitis","volume":"37","author":"Akpinar","year":"2018","journal-title":"J Med Biochem"},{"key":"R24-20240907","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5217\/ir.2019.09156","article-title":"The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis","volume":"19","author":"Jeong","year":"2021","journal-title":"Intest Res"},{"key":"R25-20240907","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/cells1020035","article-title":"Cytomegalovirus (CMV)-specific perforin and granzyme B ELISPOT assays detect reactivation of CMV infection in inflammatory bowel disease","volume":"1","author":"Nowcki","year":"2012","journal-title":"Cells"},{"key":"R26-20240907","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2008.06.002","article-title":"Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy","volume":"43","author":"D'Ovidio","year":"2008","journal-title":"J Clin Virol"},{"key":"R27-20240907","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1572-0241.2006.00989.x","article-title":"Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients","volume":"102","author":"Matsuoka","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R28-20240907","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1099\/jmm.0.45629-0","article-title":"Infection with cytomegalovirus in patients with inflammatory bowel disease:Prevalence, clinical significance and outcome","volume":"53","author":"Kishore","year":"2004","journal-title":"J Med Microbiol"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_616_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:14:30Z","timestamp":1787760870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_616_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_616_22","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2022-09-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}